Leading Technology Group approached me — what now?
An acquirer reaching out can feel like a big moment, and it’s normal to be unsure what it means or how to respond. An approach is not an offer, and it doesn’t commit you to anything — it’s the start of a conversation you get to run at your own pace.
The most useful thing to do first is slow down and understand what kind of approach this actually is. The rest of this page walks through who Leading Technology Group is, how to read the signals, and the practical moves that keep your options open.
Who they are, in short
Leading Technology Group (LTG) is a Melbourne-based, family-owned investment company founded in 1991. It holds seven businesses in clinical research, bioanalytical laboratory services, scientific instrumentation, and healthcare and research software. These include Cardiobase, Clinibase, Crux Biolabs, Emeritus Research, Millennium Science, Systematic Medicine and Veritus Research. LTG is self-funded and completes deals without debt, and it says it does not follow the typical private-equity model of a fixed-life fund working toward an exit. It is run by its own family owners, who take an active leadership role. It says it maintains ongoing relationships with the owners of businesses it acquires, most of whom keep a role afterward, though this isn't required.
Read the full profile of Leading Technology GroupWhat they look for
LTG's stated focus is service and technology businesses in medical research, life sciences, health and software. It has a long-standing concentration on biological and software products for medical and research groups, and, since 2013, a strategic emphasis on vascular- and brain-ageing research. These ventures aim to extend healthy lifespan without altering human physiology. LTG does not publish revenue, EBITDA, enterprise-value or cheque-size thresholds, a geography beyond its Australian base, a majority/minority ownership preference, or a bolt-on-versus-platform preference. What it does state is its capital model: acquisitions are self-funded, with no debt required, which it says lets it complete a deal in a matter of months.
- Sector focus
- Service and technology businesses in medical research, life sciences, health and software, with a historical concentration on biological/software products for medical and research groups and, since 2013, a stated strategic emphasis on vascular- and brain-ageing research and ventures aimed at extending peak health-span without permanently altering human physiology.
- Ownership
- Buy-and-hold-forever acquirer -- LTG states it does not buy businesses to sell later and is a 'permanent home' for the businesses it acquires, explicitly contrasting this with private-equity funds that hold for a defined period before exit.
- Capital model
- Self-funded, no-debt permanent capital -- LTG states it completes acquisitions and investments 'in a matter of months with rapid decision making and no debt required.'
- Hold period
- Permanent / indefinite -- LTG states it buys businesses 'to hold them forever' and is not seeking to sell acquired businesses later.
- Founder ownership
- LTG states it maintains 'great ongoing relationships with the owners of acquired businesses with all enjoying ongoing roles in the businesses (though not required)'; LTG itself is also family owned and run, with the owners playing an active leadership role.
How they run acquisitions
LTG describes itself as buying businesses to hold them forever, not as a fund working toward an exit. It states no defined hold period. Deals are self-funded with no debt required, which LTG says lets it move quickly, completing acquisitions and investments in a matter of months. Owners of businesses LTG acquires typically keep an ongoing role, though LTG says this isn't required. LTG positions itself as building long-term relationships with the people who built the business. LTG does not publish a diligence checklist, a first-contact process or a stage-by-stage transaction timetable.
Reading the approach
Not every approach means the same thing. A serial acquirer might be running a wide net, or might have a specific reason to want your business. Here’s how to tell the difference.
- Who sent itRoutine BD outreachAn analyst or associate, often via a generic template or LinkedIn note.Genuine intentA partner, principal, or the platform's CEO — someone who can actually transact.
- How specific it isRoutine BD outreachPraises the sector and your growth in general terms; could be sent to a hundred companies.Genuine intentReferences your actual product, customers, or numbers — they've done real homework.
- What they ask forRoutine BD outreachA quick intro call to learn more and get to know you for the future.Genuine intentA view on whether you'd consider a transaction, and often an early sense of scale.
- Their timelineRoutine BD outreachOpen-ended relationship building with no particular urgency.Genuine intentA concrete reason they're reaching out now — a fund mandate, a thesis, a nearby deal.
- Where it leadsRoutine BD outreachAdded to a pipeline and periodically checked in on.Genuine intentToward an indicative offer, diligence, and a process — if you engage.
Neither is bad, and neither is a commitment. The point is to read the approach for what it is before deciding how much time and information to give it — an early, low-specificity note rarely warrants sharing numbers, while genuine interest is worth understanding properly.
The moves that protect your position
Whatever the intent, a few simple habits keep you in control of the conversation and your information.
- Reply politely and keep the door open — you lose nothing by being courteous.
- Ask who they are, why now, and what stage of interest this is.
- Take your time; a serious buyer will wait for a considered response.
- Get your own read on what the business could be worth before discussing price.
- Loop in an adviser who represents you, not the buyer, before sharing anything sensitive.
- Don't name a price first, or react to a number floated casually on a call.
- Don't share detailed financials or customer data before there's an NDA and real intent.
- Don't negotiate against yourself by signalling how keen — or how nervous — you are.
- Don't let a single unsolicited approach turn into an exclusive, one-buyer conversation.
- Don't agree to a binding timeline or exclusivity just to keep them interested.
Common questions
- Is an approach from Leading Technology Group an offer?
- No. An approach is an expression of interest, not an offer — it commits you to nothing. Offers come much later, usually in writing as an indicative offer or term sheet, and only after both sides have chosen to engage.
- Do I have to reply straight away?
- No. There is no clock on your side of the conversation. A considered reply a week later reads better than a rushed one the same afternoon, and a genuine buyer will still be there. You set the pace.
- Should I share my financials with Leading Technology Group?
- Not in a first conversation. An early, low-specificity approach rarely warrants sharing numbers. If the conversation gets serious, information changes hands progressively and under a signed NDA — at a pace you control.
- How do I know if Leading Technology Group is serious?
- Read the approach itself: who sent it (a partner or CEO signals more intent than an analyst template), how specific it is about your actual product, customers, or numbers, and whether there is a concrete reason they are reaching out now. Generic praise that could have been sent to a hundred companies usually means a routine sweep.
- Do I need an advisor before responding?
- Not to acknowledge an email. But before sharing anything material — numbers, customer names, growth plans — a second opinion from someone whose only job is to represent you tends to pay for itself. An advisor can read the approach, tell you how much interest it really signals, and keep your options open.
- What happens if I just ignore it?
- Usually nothing bad — an unanswered email doesn't close any doors, and a genuinely interested buyer will follow up. What you give up is information: understanding why they reached out now can tell you a lot about how your business is being seen, even if you have no intention of selling.
Want a second opinion?
If it would help to talk it through with someone whose only job is to represent you — not the buyer — that’s exactly what we do. A short, no-obligation conversation is often enough to know where you stand.
General information, not legal, financial, or tax advice. Every situation is different — talk to an adviser about yours.